Skip to main content
  • More from ADA
    • Diabetes
    • Diabetes Care
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Clinical Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Browse
    • Issue Archive
    • Saved Searches
    • COVID-19 Article Collection
    • Quality Improvement Sucess Stories
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
  • Advertising
  • Reprints/Reuse
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • Instructions for Authors
    • ADA Journal Policies
  • More from ADA
    • Diabetes
    • Diabetes Care
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Browse
    • Issue Archive
    • Saved Searches
    • COVID-19 Article Collection
    • Quality Improvement Sucess Stories
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
  • Advertising
  • Reprints/Reuse
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • Instructions for Authors
    • ADA Journal Policies
Departments

Targeting IA-2 and GAD65 as a Cost-Saving Approach for Antibody Testing in Children With New-Onset Diabetes

  1. Lauren Kanner1 and
  2. M. Tracy Bekx2
  1. 1University of Iowa Carver College of Medicine, Iowa City, IA
  2. 2University of Wisconsin Madison School of Medicine and Public Health, Madison, WI
  1. Corresponding author: Lauren Kanner, lauren-kanner{at}uiowa.edu
Clinical Diabetes 2019 Jan; 37(1): 90-92. https://doi.org/10.2337/cd18-0021
PreviousNext
  • Article
  • Suppl Material
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 37 no. 1 90-92
DOI 
https://doi.org/10.2337/cd18-0021

Published By 
American Diabetes Association
Print ISSN 
0891-8929
Online ISSN 
1945-4953
History 
  • Published in print January 15, 2019.
  • Published online ahead of print September 26, 2018.

Article Versions

  • Previous version (September 26, 2018 - 07:00).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2019 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0 for details.

Author Information

  1. Lauren Kanner1 and
  2. M. Tracy Bekx2
  1. 1University of Iowa Carver College of Medicine, Iowa City, IA
  2. 2University of Wisconsin Madison School of Medicine and Public Health, Madison, WI
  1. Corresponding author: Lauren Kanner, lauren-kanner{at}uiowa.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: September 2018 to January 2021

Rendering graph...
AbstractFullPdf
Sep 20183004
Oct 201890018
Nov 20185705
Dec 201883013
Jan 201925215450
Feb 201929220651
Mar 201923118326
Apr 201911414719
May 2019576217
Jun 20191925315
Jul 20191476314
Aug 20191653612
Sep 2019225914
Oct 2019275615
Nov 201924458
Dec 2019288612
Jan 2020144910
Feb 20208356
Mar 202056910
Apr 202059312
May 2020184817
Jun 2020146114
Jul 2020135510
Aug 2020236030
Sep 20207596
Oct 2020154914
Nov 202094517
Dec 2020104113
Jan 20215174

PreviousNext
Back to top
Clinical Diabetes: 37 (1)

In this Issue

January 2019, 37(1)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by Author
  • Masthead (PDF)
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Clinical Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Targeting IA-2 and GAD65 as a Cost-Saving Approach for Antibody Testing in Children With New-Onset Diabetes
(Your Name) has forwarded a page to you from Clinical Diabetes
(Your Name) thought you would like to see this page from the Clinical Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Targeting IA-2 and GAD65 as a Cost-Saving Approach for Antibody Testing in Children With New-Onset Diabetes
Lauren Kanner, M. Tracy Bekx
Clinical Diabetes Jan 2019, 37 (1) 90-92; DOI: 10.2337/cd18-0021

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Targeting IA-2 and GAD65 as a Cost-Saving Approach for Antibody Testing in Children With New-Onset Diabetes
Lauren Kanner, M. Tracy Bekx
Clinical Diabetes Jan 2019, 37 (1) 90-92; DOI: 10.2337/cd18-0021
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Describe your practice setting and location.
    • Describe the specific quality gap addressed through the initiative.
    • How did you identify this quality gap? In other words, where did you get your baseline data?
    • Summarize the initial data for your practice (before the improvement initiative).
    • What was the timeframe from initiation of your quality improvement (QI) initiative to its completion?
    • Describe your core QI team. Who served as project leader, and why was this person selected? Who else served on the team?
    • Describe the structural changes you made to your practice through this initiative.
    • Describe the most important changes you made to your process of care delivery.
    • Optional: If you used the PDSA change model, provide details for one example in the following sections:
    • Summarize your final outcome data (at the end of the improvement initiative) and how it compared to your baseline data.
    • What are your next steps?
    • What lessons did you learn through your QI process that you would like to share with others?
    • Duality of Interest
    • Footnotes
  • Suppl Material
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

Departments

  • Case Reports on Diabetes-Related Outcomes for Pregnant Women in the National Diabetes Prevention Program
  • Transitioning to Fixed-Ratio Combination Therapy: Five Frequently Asked Questions Health Care Providers Should Anticipate From Their Patients
  • Gvoke HypoPen: An Auto-Injector Containing an Innovative, Liquid-Stable Glucagon Formulation for Use in Severe Acute Hypoglycemia
Show more Departments

Quality Improvement Success Stories

  • Design and Implementation of an Electronic Tool to Measure Medication Adherence at the Point of Care
  • Strategies to Improve Annual Diabetic Foot Screening Compliance at a Family Clinic
  • Diabetic Nephropathy Screening in a Residency Clinic: Improvements Also Reveal Limits of Healthcare Effectiveness Data and Information Set (HEDIS) Metric
Show more Quality Improvement Success Stories

Similar Articles

Navigate

  • Current Issue
  • Papers in Press
  • Abridged Standards of Care
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Diabetes Care
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Clinical Diabetes Print ISSN: 0891-8929, Online ISSN: 1945-4953.